UK markets open in 7 hours 22 minutes

Vitrolife AB (publ) (0YAY.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
301.00+1.03 (+0.34%)
At close: 05:58PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-17.45%
S&P500 52-week change 325.59%
52-week high 3331.80
52-week low 3143.90
50-day moving average 3221.54
200-day moving average 3205.89

Share statistics

Avg vol (3-month) 335.56k
Avg vol (10-day) 335.21k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 874.97M
% held by insiders 128.73%
% held by institutions 151.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.00
Trailing annual dividend yield 30.33%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 317 May 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -109.63%
Operating margin (ttm)19.86%

Management effectiveness

Return on assets (ttm)2.48%
Return on equity (ttm)-25.36%

Income statement

Revenue (ttm)3.5B
Revenue per share (ttm)25.84
Quarterly revenue growth (yoy)-1.50%
Gross profit (ttm)N/A
EBITDA 1.12B
Net income avi to common (ttm)-3.84B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)15.00%

Balance sheet

Total cash (mrq)947M
Total cash per share (mrq)6.99
Total debt (mrq)2.07B
Total debt/equity (mrq)15.64%
Current ratio (mrq)3.68
Book value per share (mrq)97.72

Cash flow statement

Operating cash flow (ttm)795M
Levered free cash flow (ttm)631.5M